General Partner @ shuckerVC. 5x Founder. 2x Dad. Journalism junkie. Tech tinkerer. Gamer. Gourmet. Dinghy sailor. Aspiring yachtsman. Mediocre handyman.
Piedmont, CA
Joined February 2009
- Tweets2.1K
- Following142
- Followers174
- Likes1.2K
I support the Mensarius Oath for ethical investing. Founders, and the rest of the startup ecosystem, deserve and need ethical investors. govclab.com/the-mensarius-oa… #MensariusOath
Bay Lights is perhaps my favorite piece of art. By chance, I happened to be running on the Embarcadero one of the first times it was illuminated. The experience was breathtaking and unforgettable. Here's hoping we make Bay Lights 360 a reality. ✨
sfchronicle.com/sf/bayarea/h…
Graham Siegel retweeted
We’re excited to announce the @EMA_News qualification of our PROCOVA™ framework to run TwinRCTs™— trials with smaller control arms. This historic milestone helps pave the way for using #AI to run more patient-centric #clinicaltrials. Read more: bwnews.pr/3dMMbF4
Graham Siegel retweeted
Breaking News! Unlearn is the first company to receive @EMA_News regulatory approval for a machine learning-based method for reducing sample size in pivotal #clinicaltrials. Read the press release here: bwnews.pr/3dMMbF4
Graham Siegel retweeted
Come be my Director and oversee the cool methodologies we’re working on! Hiring for other roles in research and applied biostats, machine learning, and others
Unlearn is hiring for a Head of Biostatistics Research and will be reviewing applications and scheduling interviews during JSM 2022. All registered applicants can apply through the JSM Career Portal, here: bit.ly/3RFitB0 @Amstatnews
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Graham Siegel retweeted
Check out the current edition of JCS to read the article “Artificial Intelligence in Clinical Research,” authored by Unlearn’s Luis Olmos and Dana Jasek to learn how the adoption of #AI-based approaches is steadily increasing within biopharma companies. bit.ly/3ua86LG
Graham Siegel retweeted
We're excited to announce that the European Medicines Agency has published a draft qualification opinion on our patent-pending PROCOVA™ method developed by @UnlearnAI. Read founder & CEO @charleskfisher's blog to learn about this important milestone: bit.ly/3iU3wem
Graham Siegel retweeted
“Using #digitaltwins in the design and analysis of a clinical trial maintains the highest standard of evidence while reducing the number of required patients." @Venturebeat writes about @UnlearnAI's partnership with @merckgroup KGaA, Darmstadt, Germany. bit.ly/3uXkv6M
Graham Siegel retweeted
“California is about to take a big step backward by setting up huge barriers for consumers to adopt solar power,” writes @Schwarzenegger, a former governor of the state. nyti.ms/3FDOxxR
Graham Siegel retweeted
It's Day 1 of #CTAD21! Visit our virtual partner space and watch Symposium RS4, featuring chair @DrJeffCummings and presenters Alejandro Schuler of @UnlearnAI and @Stanford, @PappKate of @BWHNeurology and @harvardmed, and Steven Chance of @OxfordBrain. #Alzheimers @CTADconference
Couldn’t agree more! cc @MichelleDWong
You’re unable to view this Post because this account owner limits who can view their Posts. Learn more
Graham Siegel retweeted
@UnlearnAI is one of several DCVC cos making better, safer, less expensive medicines available dramatically faster. Its ‘digital twin’ of a human patient is a huge breakthrough for the faster, more accurate, less expensive trials we need.
forbes.com/sites/ganeskesari…
Nice article by @kesaritweets in Forbes this morning about how @UnlearnAI uses digital twins to accelerate clinical trials. forbes.com/sites/ganeskesari…
